The cure fraction of glioblastoma multiforme

Neuroepidemiology

Volumn 39, Issue 1, 2012, Pages 63-69

  Smoll, Nicolas R ^a,b   Schaller, Karl ^b   Gautschi, Oliver P ^b  

^a UNIVERSITY OF BALLARAT   (Australia)

^b UNIVERSITY OF GENEVA MEDICAL SCHOOL   (Switzerland)

Author keywords

Cure fraction; Epidemiology and End Results database; Glioblastoma multiforme; Long term survival; Relative survival; Surveillance

Indexed keywords

ADULT; ARTICLE; CANCER SURGERY; CANCER SURVIVAL; CHILD; CURE FRACTION; DATA BASE; DISEASE REGISTRY; DISEASE SURVEILLANCE; FEMALE; FOLLOW UP; GLIOBLASTOMA; HUMAN; MAJOR CLINICAL STUDY; MALE; ONCOLOGICAL PARAMETERS; PRESCHOOL CHILD; SCHOOL CHILD;

ADOLESCENT; ADULT; AGED; BRAIN NEOPLASMS; CHILD; CHILD, PRESCHOOL; DISEASE-FREE SURVIVAL; FEMALE; GLIOBLASTOMA; HUMANS; INFANT; MALE; MIDDLE AGED; MODELS, STATISTICAL; SEER PROGRAM; SURVIVAL RATE; UNITED STATES;

EID: 84863521199     PISSN: 02515350     EISSN: 14230208     Source Type: Journal    
DOI: 10.1159/000339319     Document Type: Article

References (32)

1. Scott JN, Rewcastle NB, Brasher PM, Fulton D, MacKinnon JA, Hamilton M, Cairncross JG, Forsyth P: Which glioblastoma multiforme patient will become a long-term survivor? A population-based study. Ann Neurol 1999; 46: 183-188. (Pubitemid 29382874)
2. Stupp R, Mason WP, van den Bent MJ, Weller M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn U, Curschmann J, Janzer RC, Ludwin SK, Gorlia T, Allgeier A, Lacombe D, Cairncross JG, Eisenhauer E, Mirimanoff RO: Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N Engl J Med 2005; 352: 987-996. (Pubitemid 40349501)
3. Salvati M, Cervoni L, Artico M, Caruso R, Gagliardi FM: Long-term survival in patients with supratentorial glioblastoma. J Neurooncol 1998; 36: 61-64. (Pubitemid 28230653)
4. Cervoni L, Celli P, Salvati M: Long-term survival in a patient with supratentorial glioblastoma: clinical considerations. Ital J Neurol Sci 1998; 19: 221-224. (Pubitemid 128730538)
5. Bucy PC, Oberhill HR, Siqueira EB, Zimmerman HM, Jelsma RK: Cerebral glioblastomas can be cured! Neurosurgery 1985; 16: 714-717.
6. Chandler KL, Prados MD, Malec M, Wilson CB: Long-term survival in patients with glioblastoma multiforme. Neurosurgery 1993; 32: 716-720, discussion 720. (Pubitemid 23134013)
7. Bahr O, Herrlinger U, Weller M, Steinbach JP: Very late relapses in glioblastoma longterm survivors. J Neurol 2009; 256: 1756-1758.
8. Surveillance, Epidemiology and End Results (SEER) Program, SEER * Stat Database: Mortality -all COD, aggregated with state, total U.S. (1969-2006), ! katrina/rita population adjustment 1 underlying mortality data provided by NCHS (http://www.Cdc.Gov/nchs); in Cancer Statistics Branch (ed): Surveillance Research Program. Bethesda, National Cancer Institute, 2010.
9. Swaminathan R, Brenner H: Stastistical methods for cancer survival analysis. IARC Sci Publ 2011; 162: 7-13.
10. Sarfati D, Blakely T, Pearce N: Measuring cancer survival in populations: relative survival vs cancer-specific survival. Int J Epidemiol 2010; 39: 598-610.
11. Verdecchia A, De Angelis R, Capocaccia R, Sant M, Micheli A, Gatta G, Berrino F: The cure for colon cancer: results from the EUROCARE study. Int J Cancer 1998; 77: 322-329. (Pubitemid 28299863)
12. Lambert PC, Dickman PW, Osterlund P, Andersson T, Sankila R, Glimelius B: Temporal trends in the proportion cured for cancer of the colon and rectum: a populationbased study using data from the Finnish Cancer Registry. Int J Cancer 2007; 121: 2052-2059. (Pubitemid 47463170)
13. Lambert PC, Thompson JR, Weston CL, Dickman PW: Estimating and modeling the cure fraction in population-based cancer survival analysis. Biostatistics 2007; 8: 576-594.
14. Zippin C, Lum D, Hankey BF: Completeness of hospital cancer case reporting from the SEER Program of the National Cancer Institute. Cancer 1995; 76: 2343-2350.
15. International Classification of Diseases for Oncology, ed 3. Geneva, World Health Organization, 2011.
16. Kozak KR, Mahadevan A, Moody JS: Adult gliosarcoma: epidemiology, natural history, and factors associated with outcome. Neuro Oncol 2009; 11: 183-191.
17. Kozak KR, Moody JS: Giant cell glioblastoma: a glioblastoma subtype with distinct epidemiology and superior prognosis. Neuro Oncol 2009; 11: 833-841.
18. Surveillance, Epidemiology and End Results (SEER) Program: SEER 17 regs research data 1973-2007; in Cancer Statistics Branch (ed): Surveillance Research Program. Bethesda, National Cancer Institute, 2011.
19. Albritton KCM, Caligiuri M, Anderson B, Nichols C, Ulman D: Closing the Gap: Research and Care Imperatives for Adolescents and Young Adults with Cancer. Report of the Adolescent and Young Adult Oncology Progress Review Group. Bethesda, National Cancer Institute, 2006.
20. Brenner H, Gefeller O: An alternative approach to monitoring cancer patient survival. Cancer 1996; 78: 2004-2010. (Pubitemid 26360586)
21. Polley MY, Lamborn KR, Chang SM, Butowski N, Clarke JL, Prados M: Conditional probability of survival in patients with newly diagnosed glioblastoma. J Clin Oncol 2011; 29: 4175-4180.
22. Smoll NR, Villanueva EV: The epidemiology of extraneural metastases from primary brain, spinal cord, and meningeal tumors. Neurosurgery 2010; 67:E1470-E1471.
23. Varan A, Sari N, Akalan N, Soylemezoglu F, Akyuz C, Kutluk T, Buyukpamukcu M: Extraneural metastasis in intracranial tumors in children: the experience of a single center. J Neurooncol 2006; 79: 187-190. (Pubitemid 44349948)
24. Salazar OM, Rubin P: The spread of glioblastoma multiforme as a determining factor in the radiation treated volume. Int J Radiat Oncol Biol Phys 1976; 1: 627-637.
25. Barnholtz-Sloan JS, Williams VL, Maldonado JL, Shahani D, Stockwell HG, Chamberlain M, Sloan AE: Patterns of care and outcomes among elderly individuals with primary malignant astrocytoma. J Neurosurg 2008; 108: 642-648. (Pubitemid 351498955)
26. Woods LM, Rachet B, Lambert PC, Coleman MP: 'Cure' from breast cancer among two populations of women followed for 23 years after diagnosis. Ann Oncol 2009; 20: 1331-1336.
27. Gamel JW, Meyer JS, Feuer E, Miller BA: The impact of stage and histology on the longterm clinical course of 163,808 patients with breast carcinoma. Cancer 1996; 77: 1459-1464. (Pubitemid 26105380)
28. Brenner H, Hakulinen T: Are patients diagnosed with breast cancer before age 50 years ever cured? J Clin Oncol 2004; 22: 432-438 (Pubitemid 41079771)
29. Tai P, Yu E, Cserni G, Vlastos G, Royce M, Kunkler I, Vinh-Hung V: Minimum followup time required for the estimation of statistical cure of cancer patients: verification using data from 42 cancer sites in the SEER database. BMC Cancer 2005; 5: 48.
30. Sperduto CM, Chakravarti A, Aldape K, Burger P, Papermaster GB, Sperduto P: Twenty-year survival in glioblastoma: a case report and molecular profile. Int J Radiat Oncol Biol Phys 2009; 75: 1162-1165.
31. Vertosick FT Jr, Selker RG: Long-term survival after the diagnosis of malignant glioma: a series of 22 patients surviving more than 4 years after diagnosis. Surg Neurol 1992; 38: 359-363.
32. Morita M, Rosenblum MK, Bilsky MH, Fraser RA, Rosenfeld MR: Long-term survivors of glioblastoma multiforme: clinical and molecular characteristics. J Neurooncol 1996; 27: 259-266. (Pubitemid 26098125)